Skip to main content
. 2010 Feb 10;298(5):R1343–R1350. doi: 10.1152/ajpregu.00468.2009

Table 4.

Tissue weights and TG deposition, mesenteric adipocyte size, and pancreatic insulin content at 2 mo into intervention

Control Fructose Fructose + LA
BW, g 566 ± 10 568 ± 10 561 ± 10
Epididymal fat, g 9.7 ± 0.5 10.0 ± 0.5 9.9 ± 0.5
Retroperitoneal fat, g 12.7 ± 0.5 12.7 ± 1.1 11.6 ± 0.5
Mesenteric fat, g 10.4 ± 0.4 11.4 ± 0.7 10.7 ± 0.6
Subcutaneous fat, g 49 ± 3 50 ± 3 52 ± 3
Total white adipose tissue, g 82 ± 4 84 ± 4 84 ± 4
Heart, g 1.48 ± 0.03 1.49 ± 0.06 1.43 ± 0.03
Kidney, g 1.60 ± 0.04 1.62 ± 0.06 1.66 ± 0.05
Liver, g 19.1 ± 0.7 19.3 ± 0.8 20.5 ± 0.7
Liver TG, mg/g 32.7 ± 1.7 31.3 ± 3.4 42.5 ± 4.4
Muscle TG, mg/g 4.9 ± 1.2 3.7 ± 0.4 6.3 ± 1.1
Peak mesenteric adipocyte size, pl 485 ± 35 487 ± 21 531 ± 39
Pancreatic insulin content, μg/g 47 ± 9 45 ± 6 47 ± 5

Values are expressed as means ± SE. Control: n = 10, Fructose: n = 10, Fructose + LA: n = 11. For pancreatic insulin content, Control: n = 4, Fructose: n = 5, Fructose + LA: n = 5.

HHS Vulnerability Disclosure